$AFCG
Advanced Flower Capital Inc. Stock $afcg

$afcg Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000182252322000005 Filed on August 09, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022 Q1
Revenue	$18.14M	$19.90M	$17.39M
YoY Change	70.88%	127.52%	271.09%
Cost Of Revenue	$3.825M	$4.202M	$3.847M
YoY Change	50.41%	102.11%	337.18%
Gross Profit	$14.32M	$15.70M	$13.54M
YoY Change	68.96%	135.43%	255.34%
Gross Profit Margin	78.92%	78.89%	77.87%
Selling, General & Admin	$1.490M	$1.588M	$2.534M
YoY Change	14.06%	73.96%	15.17%
% of Gross Profit	10.41%	10.11%	18.72%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$5.315M	$5.790M	$6.381M
YoY Change	38.07%	93.52%	107.6%
Operating Profit	$9.002M	$9.913M	$7.157M
YoY Change	94.67%	169.53%	872.15%
Interest Expense	$1.644M	$1.747M	$1.700M
YoY Change	15.46%
% of Operating Profit	18.26%	17.62%	23.75%
Other Income/Expense, Net	-$542.0K	-$1.593M	-$905.1K
YoY Change	-17.96%	146.68%	1193.04%
Pretax Income	$11.65M	$11.52M	$10.18M
YoY Change	46.87%	148.84%	626.78%
Income Tax	$200.0K	$164.3K	$18.28K
% Of Pretax Income	1.72%	1.43%	0.18%
Net Earnings	$11.48M	$11.35M	$10.16M
YoY Change	44.76%	145.29%	625.47%
Net Earnings / Revenue	63.28%	57.03%	58.45%
Basic Earnings Per Share	$0.57	$0.58	$0.53
Diluted Earnings Per Share	$0.57	$0.57	$0.52
COMMON SHARES
Basic Shares Outstanding	19.86M shares	19.72M shares	19.32M
Diluted Shares Outstanding	20.11M shares	19.81M shares	19.59M

Balance Sheet

Concept	2022 Q3	2022 Q2	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$36.32M	$45.58M	$63.62M
YoY Change	-48.1%	-63.42%	-49.83%
Cash & Equivalents	$36.32M	$45.58M	$63.62M
Short-Term Investments
Other Short-Term Assets	$564.0K	$620.0K	$604.2K
YoY Change	44.15%	228.03%	-45.07%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$36.88M	$46.20M	$64.22M
YoY Change	-47.58%	-62.98%	-50.18%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$0.00	$0.00	$0.00
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$434.4M	$413.1M	$389.8M
YoY Change	86.04%	168.73%	320.98%
TOTAL ASSETS
Total Short-Term Assets	$36.88M	$46.20M	$64.22M
Total Long-Term Assets	$434.4M	$413.1M	$389.8M
Total Assets	$471.3M	$459.3M	$454.1M
YoY Change	55.1%	64.91%	104.99%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.131M	$986.7K	$1.616M
YoY Change	117.33%	-30.54%	303.95%
Accrued Expenses	$13.70M	$11.55M	$7.771M
YoY Change	17.65%	41.61%	72.68%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$26.25M	$23.67M	$20.27M
YoY Change	-8.8%	147.08%	289.78%
LONG-TERM LIABILITIES
Long-Term Debt	$96.96M	$96.82M	$96.66M
YoY Change
Other Long-Term Liabilities	$688.7K	$594.8K	$629.2K
YoY Change	-0.52%	24.93%	109.73%
Total Long-Term Liabilities	$97.65M	$97.42M	$97.29M
YoY Change	14006.28%	20360.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$26.25M	$23.67M	$20.27M
Total Long-Term Liabilities	$97.65M	$97.42M	$97.29M
Total Liabilities	$123.9M	$121.1M	$117.6M
YoY Change	320.33%	1104.3%	2172.15%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.489M	-$1.566M
YoY Change		104.52%
Common Stock	$203.6K	$197.9K
YoY Change		22.81%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$347.4M	$338.2M	$336.5M
YoY Change
Total Liabilities & Shareholders Equity	$471.3M	$459.3M	$454.1M
YoY Change	55.1%	64.91%	104.99%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022 Q1
OPERATING ACTIVITIES
Net Income	$11.48M	$11.35M	$10.16M
YoY Change	44.76%	145.29%	625.47%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	$12.23M	$10.56M	$4.665M
YoY Change	11033.23%	106.03%	96.79%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$19.40M	-$19.08M	-$30.05M
YoY Change	-67.55%	-65.19%	336.11%
Cash From Investing Activities	-$19.40M	-$19.08M	-$30.05M
YoY Change	-67.55%	-65.19%	336.42%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-2.096M	-9.517M	-20.25M
YoY Change	-141.6%	-120.04%	-116.64%
NET CHANGE
Cash From Operating Activities	12.23M	10.56M	4.665M
Cash From Investing Activities	-19.40M	-19.08M	-30.05M
Cash From Financing Activities	-2.096M	-9.517M	-20.25M
Net Change In Cash	-9.264M	-18.03M	-45.63M
YoY Change	-83.04%	727.54%	-138.94%
FREE CASH FLOW
Cash From Operating Activities	$12.23M	$10.56M	$4.665M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001822523
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-39995
	dei	Entity Registrant Name EntityRegistrantName	AFC GAMMA, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MD
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-1807125
	dei	Entity Address Address Line1 EntityAddressAddressLine1	525 Okeechobee Blvd., Suite 1650
	dei	Entity Address City Or Town EntityAddressCityOrTown	West Palm Beach
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33401
	dei	City Area Code CityAreaCode	561
	dei	Local Phone Number LocalPhoneNumber	510-2390
	dei	Security12b Title Security12bTitle	Common Stock, $0.01 par value per share
	dei	Trading Symbol TradingSymbol	AFCG
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	19857872	shares
CY2022Q2	afcg	Loans Held For Investment Cost LoansHeldForInvestmentCost	93940582	usd
CY2021Q4	afcg	Loans Held For Investment Cost LoansHeldForInvestmentCost	74913157	usd
CY2022Q2	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	95199132	usd
CY2021Q4	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	77096319	usd
CY2021Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	16050000	usd
CY2022Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	0	usd
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	15881250	usd
CY2022Q2	afcg	Loans Held For Investment Carrying Value LoansHeldForInvestmentCarryingValue	315882044	usd
CY2021Q4	afcg	Loans Held For Investment Carrying Value LoansHeldForInvestmentCarryingValue	257163496	usd
CY2022Q2	us-gaap	Notes Receivable Gross NotesReceivableGross	2220279	usd
CY2021Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	2530588	usd
CY2022Q2	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	5018072	usd
CY2021Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	2431558	usd
CY2022Q2	us-gaap	Notes Receivable Net NotesReceivableNet	313084251	usd
CY2021Q4	us-gaap	Notes Receivable Net NotesReceivableNet	257262526	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	45583533	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	109246048	usd
CY2022Q2	us-gaap	Interest Receivable InterestReceivable	4797315	usd
CY2021Q4	us-gaap	Interest Receivable InterestReceivable	4412938	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	619973	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	949279	usd
CY2022Q2	us-gaap	Assets Assets	459284204	usd
CY2021Q4	us-gaap	Assets Assets	464848360	usd
CY2022Q2	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	5186615	usd
CY2021Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	4782271	usd
CY2022Q2	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	958333	usd
CY2021Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	991840	usd
CY2022Q2	us-gaap	Due To Affiliate Current And Noncurrent DueToAffiliateCurrentAndNoncurrent	6140	usd
CY2021Q4	us-gaap	Due To Affiliate Current And Noncurrent DueToAffiliateCurrentAndNoncurrent	0	usd
CY2022Q2	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	11120409	usd
CY2021Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	8221406	usd
CY2022Q2	us-gaap	Financing Receivable Covered Allowance For Credit Loss FinancingReceivableCoveredAllowanceForCreditLoss	594840	usd
CY2021Q4	us-gaap	Financing Receivable Covered Allowance For Credit Loss FinancingReceivableCoveredAllowanceForCreditLoss	683177	usd
CY2022Q2	us-gaap	Management Fee Payable ManagementFeePayable	4201567	usd
CY2021Q4	us-gaap	Management Fee Payable ManagementFeePayable	2823044	usd
CY2022Q2	afcg	Accrued Direct Administrative Expenses AccruedDirectAdministrativeExpenses	1205793	usd
CY2021Q4	afcg	Accrued Direct Administrative Expenses AccruedDirectAdministrativeExpenses	1324457	usd
CY2022Q2	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	986728	usd
CY2021Q4	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	1528980	usd
CY2022Q2	us-gaap	Senior Notes SeniorNotes	96823414	usd
CY2021Q4	us-gaap	Senior Notes SeniorNotes	96572656	usd
CY2022Q2	afcg	Line Of Credit Facility Due To Affiliate Current And Noncurrent LineOfCreditFacilityDueToAffiliateCurrentAndNoncurrent	0	usd
CY2021Q4	afcg	Line Of Credit Facility Due To Affiliate Current And Noncurrent LineOfCreditFacilityDueToAffiliateCurrentAndNoncurrent	74845355	usd
CY2022Q2	us-gaap	Liabilities Liabilities	121083839	usd
CY2021Q4	us-gaap	Liabilities Liabilities	191773186	usd
CY2022Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000	shares
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000	shares
CY2022Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	125	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	125	shares
CY2022Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	125	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	125	shares
CY2022Q2	us-gaap	Preferred Stock Value PreferredStockValue	1	usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	1	usd
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	19857872	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	19857872	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	16442812	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	16442812	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	197933	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	163866	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	339568041	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	274172934	usd
CY2022Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	0	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-168750	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1565610	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1092877	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	338200365	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	273075174	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	459284204	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	464848360	usd
CY2022Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	21651207	usd
CY2021Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	8748519	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	40287060	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	13433524	usd
CY2022Q2	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	1747004	usd
CY2021Q2	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	0	usd
	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	3447119	usd
	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	0	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	19904203	usd
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8748519	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	36839941	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	13433524	usd
CY2022Q2	afcg	Accrued Exchange Fee Rebate AccruedExchangeFeeRebate	488050	usd
CY2021Q2	afcg	Accrued Exchange Fee Rebate AccruedExchangeFeeRebate	182707	usd
	afcg	Accrued Exchange Fee Rebate AccruedExchangeFeeRebate	875543	usd
	afcg	Accrued Exchange Fee Rebate AccruedExchangeFeeRebate	420450	usd
CY2022Q2	us-gaap	Labor And Related Expense LaborAndRelatedExpense	4201568	usd
CY2021Q2	us-gaap	Labor And Related Expense LaborAndRelatedExpense	2078871	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	8048781	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	2955533	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1177437	usd
CY2021Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	706865	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2321881	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1169383	usd
CY2022Q2	us-gaap	Share Based Compensation ShareBasedCompensation	117397	usd
CY2021Q2	us-gaap	Share Based Compensation ShareBasedCompensation	11457	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1107420	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1610572	usd
CY2022Q2	us-gaap	Professional Fees ProfessionalFees	293311	usd
CY2021Q2	us-gaap	Professional Fees ProfessionalFees	194594	usd
	us-gaap	Professional Fees ProfessionalFees	692679	usd
	us-gaap	Professional Fees ProfessionalFees	330047	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	5789713	usd
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	2991787	usd
	us-gaap	Operating Expenses OperatingExpenses	12170761	usd
	us-gaap	Operating Expenses OperatingExpenses	6065535	usd
CY2022Q2	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	1593048	usd
CY2021Q2	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	645786	usd
	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	2498177	usd
	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	711886	usd
CY2022Q2	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	0	usd
CY2021Q2	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	0	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	450000	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	0	usd
CY2022Q2	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-1005454	usd
CY2021Q2	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-483159	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-924611	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-627561	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	11515988	usd
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	4627787	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	21696392	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	6028542	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	164315	usd
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	182599	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	11351673	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	4627787	usd
	us-gaap	Net Income Loss NetIncomeLoss	21513793	usd
	us-gaap	Net Income Loss NetIncomeLoss	6028542	usd
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.58
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.34
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.10
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.58
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.57
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.34
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.10
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.57
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19715749	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13457536	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19518964	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10318542	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19811594	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13775246	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19614809	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10636252	shares
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	11351673	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	4627787	usd
	us-gaap	Net Income Loss NetIncomeLoss	21513793	usd
	us-gaap	Net Income Loss NetIncomeLoss	6028542	usd
CY2022Q2	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	0	usd
CY2021Q2	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	0	usd
	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	168750	usd
	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	0	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	0	usd
CY2021Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	0	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	168750	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	0	usd
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	11351673	usd
CY2021Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	4627787	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	21682543	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	6028542	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	336510393	usd
CY2022Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1348811	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	117397	usd
CY2022Q2	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.56
CY2022Q2	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	11120409	usd
CY2022Q2	us-gaap	Preferred Stock Dividends Per Share Cash Paid PreferredStockDividendsPerShareCashPaid	60
CY2022Q2	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	7500	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	11351673	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	338200365	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	216332005	usd
CY2021Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	52572386	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	11457	usd
CY2021Q2	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.38
CY2021Q2	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	5079413	usd
CY2021Q2	us-gaap	Preferred Stock Dividends Per Share Cash Paid PreferredStockDividendsPerShareCashPaid	60
CY2021Q2	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	7500	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	4627787	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	268456722	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	273075174	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	64321754	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1107420	usd
	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	1.11
	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	21979026	usd
	us-gaap	Preferred Stock Dividends Per Share Cash Paid PreferredStockDividendsPerShareCashPaid	60
	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	7500	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	168750	usd
	us-gaap	Net Income Loss NetIncomeLoss	21513793	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	338200365	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	91647712	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	176481675	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1610572	usd
	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.74
	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	7304279	usd
	us-gaap	Preferred Stock Dividends Per Share Cash Paid PreferredStockDividendsPerShareCashPaid	60
	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	7500	usd
	us-gaap	Net Income Loss NetIncomeLoss	6028542	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	268456722	usd
	us-gaap	Net Income Loss NetIncomeLoss	21513793	usd
	us-gaap	Net Income Loss NetIncomeLoss	6028542	usd
	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	2498177	usd
	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	711886	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	450000	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	0	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-924611	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-627561	usd
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	8337513	usd
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	2275032	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	507883	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	0	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1107420	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1610572	usd
	afcg	Payment In Kind Interest PaymentInKindInterest	3475182	usd
	afcg	Payment In Kind Interest PaymentInKindInterest	1267093	usd
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	384377	usd
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	223377	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-226826	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	116905	usd
	afcg	Increase Decrease In Interest Reserve IncreaseDecreaseInInterestReserve	-404344	usd
	afcg	Increase Decrease In Interest Reserve IncreaseDecreaseInInterestReserve	702887	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-33507	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	0	usd
	us-gaap	Increase Decrease In Other Employee Related Liabilities IncreaseDecreaseInOtherEmployeeRelatedLiabilities	1378523	usd
	us-gaap	Increase Decrease In Other Employee Related Liabilities IncreaseDecreaseInOtherEmployeeRelatedLiabilities	1856744	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-118664	usd
	us-gaap	Payments To Acquire Loans Held For Investment PaymentsToAcquireLoansHeldForInvestment	76918926	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-19732	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-536112	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	1265608	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	15226222	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	7495887	usd
	us-gaap	Payments To Acquire Loans Held For Investment PaymentsToAcquireLoansHeldForInvestment	103799812	usd
	us-gaap	Proceeds From Sale Of Other Investments ProceedsFromSaleOfOtherInvestments	0	usd
	us-gaap	Proceeds From Sale Of Other Investments ProceedsFromSaleOfOtherInvestments	2313130	usd
	us-gaap	Proceeds From Sale Of Loans Held For Investment ProceedsFromSaleOfLoansHeldForInvestment	10600000	usd
	us-gaap	Proceeds From Sale Of Loans Held For Investment ProceedsFromSaleOfLoansHeldForInvestment	0	usd
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	15900000	usd
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0	usd
	us-gaap	Proceeds From Principal Repayments On Loans And Leases Held For Investment ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment	28176844	usd
	us-gaap	Proceeds From Principal Repayments On Loans And Leases Held For Investment ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment	12921065	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-49122968	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-61684731	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	65971445	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	180277500	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	1649691	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	3795825	usd
	us-gaap	Payments Of Dividends PaymentsOfDividends	19087523	usd
	us-gaap	Payments Of Dividends PaymentsOfDividends	7311779	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	75000000	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-29765769	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	169169896	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-63662515	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	114981052	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	109246048	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9623820	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	45583533	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	124604872	usd
	afcg	Interest Reserve Withheld From Funding Of Loan InterestReserveWithheldFromFundingOfLoan	0	usd
	afcg	Interest Reserve Withheld From Funding Of Loan InterestReserveWithheldFromFundingOfLoan	4925000	usd
	afcg	Original Issue Discount Withheld From Funding Of Loans OriginalIssueDiscountWithheldFromFundingOfLoans	4682675	usd
	afcg	Original Issue Discount Withheld From Funding Of Loans OriginalIssueDiscountWithheldFromFundingOfLoans	8075730	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	168750	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	0	usd
CY2022Q2	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	11120409	usd
CY2021Q2	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	0	usd
	us-gaap	Interest Paid Net InterestPaidNet	2972743	usd
	us-gaap	Interest Paid Net InterestPaidNet	0	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	40588	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates in the Preparation of Financial Statements</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Actual results could differ from those estimates. Significant estimates include the valuation of loans held for investment at fair value and current expected credit losses (“CECL”).</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Over the course of the coronavirus (“COVID-19”) pandemic, medical cannabis companies have been deemed “essential” by almost all states with legalized cannabis and stay-at-home orders. Consequently, the impact of the COVID-19 pandemic and the related regulatory and private sector response on our financial and operating results for the</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> periods ended June 30, 2022 and 2021 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">was somewhat mitigated as all of our borrowers were permitted to continue to operate during this pandemic. Regardless, the full extent of the economic impact of the business disruptions caused by COVID-19 is uncertain. The outbreak of COVID-19 has severely impacted global economic activity and caused significant volatility and negative pressure in financial markets. The global impact of the outbreak has been rapidly evolving, and many countries, including the United States, have reacted by instituting quarantines, mandating business and school closures and restricting travel. As a result, the COVID-19 pandemic is negatively impacting almost every industry directly or indirectly, including the regulated cannabis industry. Although most of these measures have been lifted or scaled back, surges of COVID-19 in certain parts of the world, including the United States, have resulted and may in the future result in the re-imposition of certain restrictions and may lead to more restrictions to reduce the spread of COVID-19. The full effect that these disruptions may have on the operations and financial performance of the Company will depend on future developments, including possible impacts on the performance of the Company’s loans, general business activity, and ability to generate revenue, which cannot be determined.</span></div>
CY2021	afcg	Number Of Loans Held For Investments In Portfolio NumberOfLoansHeldForInvestmentsInPortfolio	3	loan
	afcg	Number Of Loans Held For Investments In Portfolio NumberOfLoansHeldForInvestmentsInPortfolio	3	loan
CY2022Q2	afcg	Loans Held For Investment At Fair Value Aggregate Commitments LoansHeldForInvestmentAtFairValueAggregateCommitments	96200000	usd
CY2021Q4	afcg	Loans Held For Investment At Fair Value Aggregate Commitments LoansHeldForInvestmentAtFairValueAggregateCommitments	75900000	usd
CY2022Q2	afcg	Loans Held For Investment Outstanding Principal Amount LoansHeldForInvestmentOutstandingPrincipalAmount	96400000	usd
CY2021Q4	afcg	Loans Held For Investment Outstanding Principal Amount LoansHeldForInvestmentOutstandingPrincipalAmount	77600000	usd
	afcg	Loans Held For Investment At Fair Value Funded Of Outstanding Principal LoansHeldForInvestmentAtFairValueFundedOfOutstandingPrincipal	17300000	usd
CY2022Q2	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	95199132	usd
CY2022Q2	afcg	Loans Held For Investment Cost LoansHeldForInvestmentCost	93940582	usd
CY2022Q2	afcg	Loans Held For Investment Outstanding Principal Amount LoansHeldForInvestmentOutstandingPrincipalAmount	96382983	usd
	afcg	Loans Held For Investment At Fair Value Weighted Average Remaining Life LoansHeldForInvestmentAtFairValueWeightedAverageRemainingLife	P1Y8M12D
CY2021Q4	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	77096319	usd
CY2021Q4	afcg	Loans Held For Investment Cost LoansHeldForInvestmentCost	74913157	usd
CY2021Q4	afcg	Loans Held For Investment Outstanding Principal Amount LoansHeldForInvestmentOutstandingPrincipalAmount	77630742	usd
CY2021	afcg	Loans Held For Investment At Fair Value Weighted Average Remaining Life LoansHeldForInvestmentAtFairValueWeightedAverageRemainingLife	P2Y2M12D
CY2021Q4	afcg	Loans Held For Investment Outstanding Principal Amount LoansHeldForInvestmentOutstandingPrincipalAmount	77630742	usd
CY2021Q4	afcg	Loans Held For Investment At Fair Value Original Issue Discount LoansHeldForInvestmentAtFairValueOriginalIssueDiscount	2717584	usd
CY2021Q4	afcg	Loans Held For Investment At Fair Value Unrealized Gains Losses LoansHeldForInvestmentAtFairValueUnrealizedGainsLosses	2183161	usd
CY2021Q4	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	77096319	usd
	afcg	Loans Held For Investment At Fair Value Principal Change In Unrealized Gains Losses On Loans At Fair Value Net LoansHeldForInvestmentAtFairValuePrincipalChangeInUnrealizedGainsLossesOnLoansAtFairValueNet	0	usd
	afcg	Loans Held For Investment At Fair Value Original Issue Discount Change In Unrealized Gains Losses On Loans At Fair Value Net LoansHeldForInvestmentAtFairValueOriginalIssueDiscountChangeInUnrealizedGainsLossesOnLoansAtFairValueNet	0	usd
	afcg	Loans Held For Investment At Fair Value Unrealized Gains Losses Change In Unrealized Gains Losses On Loans At Fair Value Net LoansHeldForInvestmentAtFairValueUnrealizedGainsLossesChangeInUnrealizedGainsLossesOnLoansAtFairValueNet	-924611	usd
	afcg	Loans Held For Investment At Fair Value Change In Unrealized Gains Losses On Loans At Fair Value Net LoansHeldForInvestmentAtFairValueChangeInUnrealizedGainsLossesOnLoansAtFairValueNet	-924611	usd
	afcg	Loans Held For Investment At Fair Value Outstanding Principal New Fundings LoansHeldForInvestmentAtFairValueOutstandingPrincipalNewFundings	17285000	usd
	afcg	Loans Held For Investment At Fair Value Original Issue Discount Net Of Costs LoansHeldForInvestmentAtFairValueOriginalIssueDiscountNetOfCosts	429275	usd
	afcg	Loans Held For Investment At Fair Value Unrealized Gains Losses New Fundings LoansHeldForInvestmentAtFairValueUnrealizedGainsLossesNewFundings	0	usd
	afcg	Loans Held For Investment At Fair Value New Funding LoansHeldForInvestmentAtFairValueNewFunding	16855725	usd
	afcg	Loans Held For Investment At Fair Value Outstanding Principal Accretion Of Original Issue Discount LoansHeldForInvestmentAtFairValueOutstandingPrincipalAccretionOfOriginalIssueDiscount	0	usd
	afcg	Loans Held For Investment At Fair Value Original Issue Discount Accretion Of Original Issue Discount LoansHeldForInvestmentAtFairValueOriginalIssueDiscountAccretionOfOriginalIssueDiscount	704458	usd
	afcg	Loans Held For Investment At Fair Value Unrealized Gains Losses Accretion Of Original Issue Discount LoansHeldForInvestmentAtFairValueUnrealizedGainsLossesAccretionOfOriginalIssueDiscount	0	usd
	afcg	Loans Held For Investment At Fair Value Accretion Of Original Issue Discount LoansHeldForInvestmentAtFairValueAccretionOfOriginalIssueDiscount	704458	usd
	afcg	Loans Held For Investment At Fair Value Outstanding Principal Payment In Kind Interest LoansHeldForInvestmentAtFairValueOutstandingPrincipalPaymentInKindInterest	1467241	usd
	afcg	Loans Held For Investment At Fair Value Original Issue Discount Payment In Kind Interest LoansHeldForInvestmentAtFairValueOriginalIssueDiscountPaymentInKindInterest	0	usd
	afcg	Loans Held For Investment At Fair Value Unrealized Gains Losses Payment In Kind Interest LoansHeldForInvestmentAtFairValueUnrealizedGainsLossesPaymentInKindInterest	0	usd
	afcg	Loans Held For Investment At Fair Value Payment In Kind Interest LoansHeldForInvestmentAtFairValuePaymentInKindInterest	1467241	usd
CY2022Q2	afcg	Loans Held For Investment Outstanding Principal Amount LoansHeldForInvestmentOutstandingPrincipalAmount	96382983	usd
CY2022Q2	afcg	Loans Held For Investment At Fair Value Original Issue Discount LoansHeldForInvestmentAtFairValueOriginalIssueDiscount	2442401	usd
CY2022Q2	afcg	Loans Held For Investment At Fair Value Unrealized Gains Losses LoansHeldForInvestmentAtFairValueUnrealizedGainsLosses	1258550	usd
CY2022Q2	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	95199132	usd
CY2022Q2	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	95199132	usd
CY2022Q2	afcg	Loans Held For Investment Cost LoansHeldForInvestmentCost	93940582	usd
CY2022Q2	afcg	Loans Held For Investment Outstanding Principal Amount LoansHeldForInvestmentOutstandingPrincipalAmount	96382983	usd
	afcg	Number Of Loans Held For Investments NumberOfLoansHeldForInvestments	9	loan
CY2021	afcg	Number Of Loans Held For Investments NumberOfLoansHeldForInvestments	12	loan
CY2022Q2	afcg	Loans Held For Investment At Carrying Value Aggregate Commitments LoansHeldForInvestmentAtCarryingValueAggregateCommitments	383000000	usd
CY2021Q4	afcg	Loans Held For Investment At Carrying Value Aggregate Commitments LoansHeldForInvestmentAtCarryingValueAggregateCommitments	324300000	usd
CY2022Q2	us-gaap	Receivable With Imputed Interest Face Amount ReceivableWithImputedInterestFaceAmount	326200000	usd
CY2021Q4	us-gaap	Receivable With Imputed Interest Face Amount ReceivableWithImputedInterestFaceAmount	270800000	usd
	afcg	Loans Held For Investment At Carrying Value Outstanding Principal New Fundings LoansHeldForInvestmentAtCarryingValueOutstandingPrincipalNewFundings	116200000	usd
CY2022Q2	afcg	Percentage Of Loans Held With Floating Interest Rates PercentageOfLoansHeldWithFloatingInterestRates	0.38
CY2021Q4	afcg	Percentage Of Loans Held With Floating Interest Rates PercentageOfLoansHeldWithFloatingInterestRates	0.48
CY2022Q2	us-gaap	Receivable With Imputed Interest Discount ReceivableWithImputedInterestDiscount	10299185	usd
CY2021	afcg	Loans Held For Investment Weighted Average Remaining Life LoansHeldForInvestmentWeightedAverageRemainingLife	P3Y4M24D
CY2022Q2	us-gaap	Receivable With Imputed Interest Face Amount ReceivableWithImputedInterestFaceAmount	326181229	usd
CY2022Q2	afcg	Loans Held For Investment Carrying Value LoansHeldForInvestmentCarryingValue	315882044	usd
	afcg	Loans Held For Investment Weighted Average Remaining Life LoansHeldForInvestmentWeightedAverageRemainingLife	P2Y10M24D
CY2021Q4	us-gaap	Receivable With Imputed Interest Face Amount ReceivableWithImputedInterestFaceAmount	270841715	usd
CY2021Q4	us-gaap	Receivable With Imputed Interest Discount ReceivableWithImputedInterestDiscount	13678219	usd
CY2021Q4	afcg	Loans Held For Investment Carrying Value LoansHeldForInvestmentCarryingValue	257163496	usd
CY2021Q4	us-gaap	Receivable With Imputed Interest Face Amount ReceivableWithImputedInterestFaceAmount	270841715	usd
CY2021Q4	us-gaap	Receivable With Imputed Interest Discount ReceivableWithImputedInterestDiscount	13678219	usd
CY2021Q4	afcg	Loans Held For Investment Carrying Value LoansHeldForInvestmentCarryingValue	257163496	usd
	afcg	Receivable With Imputed Interest New Funding Face Amount ReceivableWithImputedInterestNewFundingFaceAmount	116200972	usd
	afcg	Receivable With Imputed Interest Discount On New Funding ReceivableWithImputedInterestDiscountOnNewFunding	4253401	usd
	afcg	Receivable With Imputed Interest New Funding Net Amount ReceivableWithImputedInterestNewFundingNetAmount	111947571	usd
	afcg	Accretion Of Original Issue Discount Principle AccretionOfOriginalIssueDiscountPrinciple	0	usd
	afcg	Receivable With Imputed Interest Loan Repayments Original Issue Discount ReceivableWithImputedInterestLoanRepaymentsOriginalIssueDiscount	0	usd
	afcg	Receivable With Imputed Interest Loan Repayments ReceivableWithImputedInterestLoanRepayments	52014211	usd
CY2022Q2	afcg	Loans Receivable At Carrying Value Aggregate Commitments LoansReceivableAtCarryingValueAggregateCommitments	4000000	usd
CY2022Q2	afcg	Loans Held For Investment Carrying Value LoansHeldForInvestmentCarryingValue	315882044	usd
	afcg	Receivable With Imputed Interest Sale Of Loans Face Amount ReceivableWithImputedInterestSaleOfLoansFaceAmount	10000000	usd
	afcg	Receivable With Imputed Interest Sale Of Loans Original Issue Discount ReceivableWithImputedInterestSaleOfLoansOriginalIssueDiscount	0	usd
	afcg	Receivable With Sale Of Loans Net Amount ReceivableWithSaleOfLoansNetAmount	10000000	usd
	afcg	Receivable With Paid In Kind Interest Face Amount ReceivableWithPaidInKindInterestFaceAmount	1981755	usd
CY2022Q2	us-gaap	Receivable With Imputed Interest Face Amount ReceivableWithImputedInterestFaceAmount	326181229	usd
	afcg	Receivable With Accretion Of Original Issue Discount Premium ReceivableWithAccretionOfOriginalIssueDiscountPremium	7632435	usd
	afcg	Accretion Of Original Issue Discount Net Amount AccretionOfOriginalIssueDiscountNetAmount	7632435	usd
	afcg	Receivable With Imputed Interest Loan Repayments Face Amount ReceivableWithImputedInterestLoanRepaymentsFaceAmount	52014211	usd
	afcg	Receivable With Paid In Kind Interest Original Issue Discount ReceivableWithPaidInKindInterestOriginalIssueDiscount	0	usd
	afcg	Receivable With Paid In Kind Interest Net Amount ReceivableWithPaidInKindInterestNetAmount	1981755	usd
	afcg	Receivable With Imputed Interest Amortization Payments ReceivableWithImputedInterestAmortizationPayments	829002	usd
	afcg	Receivable With Imputed Interest Amortization Payments Original Issue Discount ReceivableWithImputedInterestAmortizationPaymentsOriginalIssueDiscount	0	usd
	afcg	Receivable With Imputed Interest Loan Amortization Payments ReceivableWithImputedInterestLoanAmortizationPayments	829002	usd
CY2022Q2	us-gaap	Receivable With Imputed Interest Face Amount ReceivableWithImputedInterestFaceAmount	326181229	usd
CY2022Q2	us-gaap	Receivable With Imputed Interest Discount ReceivableWithImputedInterestDiscount	10299185	usd
CY2021Q4	us-gaap	Financing Receivable Unamortized Loan Commitment Origination Fee And Premium Discount FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount	2678	usd
	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	337114	usd
	afcg	Payments On Loans Receivable Original Issue Discount PaymentsOnLoansReceivableOriginalIssueDiscount	0	usd
	afcg	Payments On Loans Receivable Carrying Value PaymentsOnLoansReceivableCarryingValue	337114	usd
CY2021Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	2530588	usd
CY2022Q2	us-gaap	Receivable With Imputed Interest Discount ReceivableWithImputedInterestDiscount	10299185	usd
CY2022Q2	afcg	Loans Held For Investment Carrying Value LoansHeldForInvestmentCarryingValue	315882044	usd
CY2022Q2	afcg	Number Of Portfolio Loans NumberOfPortfolioLoans	1	loan
CY2021Q4	afcg	Number Of Portfolio Loans NumberOfPortfolioLoans	1	loan
CY2021Q4	afcg	Loans Receivable At Carrying Value Aggregate Commitments LoansReceivableAtCarryingValueAggregateCommitments	4000000	usd
CY2022Q2	us-gaap	Financing Receivable Before Allowance For Credit Loss And Fee FinancingReceivableBeforeAllowanceForCreditLossAndFee	2200000	usd
CY2021Q4	us-gaap	Financing Receivable Before Allowance For Credit Loss And Fee FinancingReceivableBeforeAllowanceForCreditLossAndFee	2500000	usd
	us-gaap	Proceeds From Collection Of Loans Receivable ProceedsFromCollectionOfLoansReceivable	300000	usd
CY2021Q4	us-gaap	Financing Receivable Before Allowance For Credit Loss And Fee FinancingReceivableBeforeAllowanceForCreditLossAndFee	2533266	usd
CY2022Q2	us-gaap	Financing Receivable Unamortized Loan Commitment Origination Fee And Premium Discount FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount	2060	usd
CY2022Q2	us-gaap	Notes Receivable Gross NotesReceivableGross	2220279	usd
	afcg	Accretion Of Original Issue Discount At Principle AccretionOfOriginalIssueDiscountAtPrinciple	0	usd
	afcg	Accretion Of Original Issue Discount AccretionOfOriginalIssueDiscount	618	usd
	afcg	Accretion Of Original Issue Discount At Carrying Value AccretionOfOriginalIssueDiscountAtCarryingValue	618	usd
	afcg	Paid In Kind Interest Principal PaidInKindInterestPrincipal	26187	usd
	afcg	Paid In Kind Interest Original Issue Discount PaidInKindInterestOriginalIssueDiscount	0	usd
	us-gaap	Paid In Kind Interest PaidInKindInterest	26187	usd
CY2022Q2	us-gaap	Financing Receivable Before Allowance For Credit Loss And Fee FinancingReceivableBeforeAllowanceForCreditLossAndFee	2222339	usd
CY2022Q2	us-gaap	Financing Receivable Originated In Current Fiscal Year FinancingReceivableOriginatedInCurrentFiscalYear	82403524	usd
CY2022Q2	us-gaap	Financing Receivable Originated In Fiscal Year Before Latest Fiscal Year FinancingReceivableOriginatedInFiscalYearBeforeLatestFiscalYear	209602563	usd
CY2022Q2	us-gaap	Financing Receivable Originated Two Years Before Latest Fiscal Year FinancingReceivableOriginatedTwoYearsBeforeLatestFiscalYear	26096236	usd
CY2022Q2	afcg	Loans Held For Investment And Financing Receivable Before Allowance For Credit Loss LoansHeldForInvestmentAndFinancingReceivableBeforeAllowanceForCreditLoss	318102323	usd
CY2022Q2	afcg	Reserves Disbursed Interest ReservesDisbursedInterest	1420548	usd
CY2021Q2	afcg	Reserves Disbursed Interest ReservesDisbursedInterest	620621	usd
CY2022Q2	afcg	Interest Receivables InterestReceivables	4072292	usd
CY2021Q4	afcg	Interest Receivables InterestReceivables	3562566	usd
CY2022Q2	afcg	Payment In Kind Receivable PaymentInKindReceivable	546790	usd
CY2021Q4	afcg	Payment In Kind Receivable PaymentInKindReceivable	554357	usd
CY2022Q2	afcg	Unused Fees Receivable UnusedFeesReceivable	178233	usd
CY2021Q4	afcg	Unused Fees Receivable UnusedFeesReceivable	296015	usd
CY2022Q2	us-gaap	Interest Receivable InterestReceivable	4797315	usd
CY2021Q4	us-gaap	Interest Receivable InterestReceivable	4412938	usd
	afcg	New Reserves Interest NewReservesInterest	6000000	usd
	afcg	New Reserves Interest NewReservesInterest	4925000	usd
	afcg	Reserves Disbursed Interest ReservesDisbursedInterest	5595656	usd
	afcg	Reserves Disbursed Interest ReservesDisbursedInterest	702887	usd
CY2022Q2	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	5186615	usd
	afcg	Number Of Loans Included In Loan Funded Interest Reserve NumberOfLoansIncludedInLoanFundedInterestReserve	2	loan
CY2021	afcg	Number Of Loans Included In Loan Funded Interest Reserve NumberOfLoansIncludedInLoanFundedInterestReserve	7	loan
CY2022Q2	afcg	Reserves Disbursed Interest ReservesDisbursedInterest	1400000	usd
	afcg	Reserves Disbursed Interest ReservesDisbursedInterest	5600000	usd
CY2022Q1	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	607163	usd
CY2021Q1	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	3243484	usd
CY2021Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	4782271	usd
CY2020Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	1325750	usd
CY2022Q2	afcg	New Reserves Interest NewReservesInterest	6000000	usd
CY2021Q2	afcg	New Reserves Interest NewReservesInterest	2925000	usd
CY2021Q2	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	5547863	usd
CY2022Q2	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	5186615	usd
CY2021Q2	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	5547863	usd
CY2022Q2	afcg	Line Of Credit Facility Accordion Feature Increase Limit LineOfCreditFacilityAccordionFeatureIncreaseLimit	100000000.0	usd
	afcg	Debt Instrument Redemption Price Change Of Control Triggering Event Percentage DebtInstrumentRedemptionPriceChangeOfControlTriggeringEventPercentage	1.01
	us-gaap	Interest Expense InterestExpense	0	usd
CY2021Q2	us-gaap	Interest Expense InterestExpense	0	usd
CY2022Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	1437499	usd
CY2022Q2	us-gaap	Line Of Credit Facility Commitment Fee Amount LineOfCreditFacilityCommitmentFeeAmount	14583	usd
CY2022Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	294922	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	1747004	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	2878819	usd
	us-gaap	Line Of Credit Facility Commitment Fee Amount LineOfCreditFacilityCommitmentFeeAmount	60417	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	507883	usd
	us-gaap	Interest Expense InterestExpense	3447119	usd
CY2022Q2	afcg	Contractual Obligation Loan Commitments ContractualObligationLoanCommitments	483181394	usd
CY2021Q4	afcg	Contractual Obligation Loan Commitments ContractualObligationLoanCommitments	419198125	usd
CY2022Q2	afcg	Contractual Obligation Drawn Loan Commitments ContractualObligationDrawnLoanCommitments	421199287	usd
CY2021Q4	afcg	Contractual Obligation Drawn Loan Commitments ContractualObligationDrawnLoanCommitments	363659505	usd
CY2022Q2	us-gaap	Contractual Obligation ContractualObligation	61982107	usd
CY2021Q4	us-gaap	Contractual Obligation ContractualObligation	55538620	usd
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2021Q1	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	123900000	usd
CY2022Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	3000000	shares
CY2022Q1	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	20.50
CY2022Q1	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	61500000	usd
CY2022Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	3291832	shares
CY2022Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	67500000	usd
CY2022Q1	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	63000000.0	usd
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	20.18
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	325114	shares
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	183114	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	2049518	shares
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	1449518	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares	58526	shares
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares	28396	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2316106	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1604236	shares
CY2022Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	117397	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1107420	usd
CY2021Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	11457	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1610572	usd
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2321106	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.21
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2022Q2	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	5000	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.43
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2316106	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.21
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1616098	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.08
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2021Q2	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	3000	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.31
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1604236	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.08
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1613098	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.08
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	742000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.46
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	30130	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.05
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2316106	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.21
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	926898	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.91
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	689200	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.31
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	3000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.31
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1613098	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.08
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.34
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.10
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.58
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.10
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.57
	afcg	Debt Securities Held At Fair Value Change In Accumulated Other Comprehensive Income DebtSecuritiesHeldAtFairValueChangeInAccumulatedOtherComprehensiveIncome	168750	usd
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.57
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.34
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	11351673	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	4627787	usd
	us-gaap	Net Income Loss NetIncomeLoss	21513793	usd
	us-gaap	Net Income Loss NetIncomeLoss	6028542	usd
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19715749	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13457536	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19518964	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10318542	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19811594	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13775246	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19614809	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10636252	shares
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.58
	afcg	Debt Securities Held At Fair Value Original Issue Discount Realized Gains Losses On Loans At Fair Value Net DebtSecuritiesHeldAtFairValueOriginalIssueDiscountRealizedGainsLossesOnLoansAtFairValueNet	-150000	usd
	afcg	Debt Securities Held At Fair Value Realized Gains Losses Change In Unrealized Gains Losses On Loans At Fair Value Net DebtSecuritiesHeldAtFairValueRealizedGainsLossesChangeInUnrealizedGainsLossesOnLoansAtFairValueNet	0	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	164315	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	182599	usd
CY2021Q2	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	0	usd
	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	0	usd
CY2022Q2	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	0	usd
	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	0	usd
	afcg	Exercise Tax As A Percentage Of Undistributed Ordinary Income And Net Capital Gains ExerciseTaxAsAPercentageOfUndistributedOrdinaryIncomeAndNetCapitalGains	0.04
CY2022Q2	afcg	Exercise Tax As A Percentage Of Undistributed Ordinary Income And Net Capital Gains ExerciseTaxAsAPercentageOfUndistributedOrdinaryIncomeAndNetCapitalGains	0.04
CY2022Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
	afcg	Debt Securities Held At Fair Value Change In Realized Gains Losses On Loans At Fair Value Net DebtSecuritiesHeldAtFairValueChangeInRealizedGainsLossesOnLoansAtFairValueNet	-150000	usd
	afcg	Debt Securities Held At Fair Value Value Outstanding Principal Change In Accumulated Other Comprehensive Income DebtSecuritiesHeldAtFairValueValueOutstandingPrincipalChangeInAccumulatedOtherComprehensiveIncome	0	usd
	afcg	Debt Securities Held At Fair Value Original Issue Discount Change In Accumulated Other Comprehensive Income DebtSecuritiesHeldAtFairValueOriginalIssueDiscountChangeInAccumulatedOtherComprehensiveIncome	0	usd
	afcg	Debt Securities Held At Fair Value Unrealized Gains Losses Change In Accumulated Other Comprehensive Income DebtSecuritiesHeldAtFairValueUnrealizedGainsLossesChangeInAccumulatedOtherComprehensiveIncome	168750	usd
CY2022Q2	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	95199132	usd
CY2022Q2	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	95199132	usd
CY2021Q4	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	77096319	usd
CY2021Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	77096319	usd
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	15900000	usd
	afcg	Debt Securities Held At Fair Value Change In Accumulated Other Comprehensive Income DebtSecuritiesHeldAtFairValueChangeInAccumulatedOtherComprehensiveIncome	200000	usd
CY2021Q4	afcg	Debt Securities Held At Fair Value Outstanding Principal Amount DebtSecuritiesHeldAtFairValueOutstandingPrincipalAmount	15000000	usd
CY2021Q4	afcg	Debt Securities Held At Fair Value Original Issue Discount DebtSecuritiesHeldAtFairValueOriginalIssueDiscount	1050000	usd
CY2021Q4	afcg	Debt Securities Held At Fair Value Unrealized Gains Losses DebtSecuritiesHeldAtFairValueUnrealizedGainsLosses	-168750	usd
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	15881250	usd
	afcg	Debt Securities Held At Fair Value Outstanding Principal Change In Realized Gains Losses On Loans At Fair Value Net DebtSecuritiesHeldAtFairValueOutstandingPrincipalChangeInRealizedGainsLossesOnLoansAtFairValueNet	0	usd
	afcg	Debt Securities Held At Fair Value Value Outstanding Principal Sale Of Securities DebtSecuritiesHeldAtFairValueValueOutstandingPrincipalSaleOfSecurities	15000000	usd
	afcg	Debt Securities Held At Fair Value Original Issue Discount Sale Of Securities DebtSecuritiesHeldAtFairValueOriginalIssueDiscountSaleOfSecurities	900000	usd
	afcg	Debt Securities Held At Fair Value Unrealized Gains Losses Sale Of Securities DebtSecuritiesHeldAtFairValueUnrealizedGainsLossesSaleOfSecurities	0	usd
	afcg	Debt Securities Held At Fair Value Sale Of Securities DebtSecuritiesHeldAtFairValueSaleOfSecurities	15900000	usd
CY2022Q2	afcg	Debt Securities Held At Fair Value Outstanding Principal Amount DebtSecuritiesHeldAtFairValueOutstandingPrincipalAmount	0	usd
CY2022Q2	afcg	Debt Securities Held At Fair Value Original Issue Discount DebtSecuritiesHeldAtFairValueOriginalIssueDiscount	0	usd
CY2022Q2	afcg	Debt Securities Held At Fair Value Unrealized Gains Losses DebtSecuritiesHeldAtFairValueUnrealizedGainsLosses	0	usd
CY2022Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	0	usd
CY2022Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	0	usd
CY2022Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	0	usd
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	15881250	usd
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	15881250	usd
CY2021Q2	afcg	Incentive Compensation IncentiveCompensation	1442047	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	45583533	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	45583533	usd
CY2022Q2	afcg	Loans Held For Investment Carrying Value LoansHeldForInvestmentCarryingValue	315882044	usd
CY2022Q2	afcg	Loans Held For Investment Fair Value LoansHeldForInvestmentFairValue	312489029	usd
CY2022Q2	us-gaap	Notes Receivable Gross NotesReceivableGross	2220279	usd
CY2022Q2	afcg	Loans And Leases Receivable Fair Value LoansAndLeasesReceivableFairValue	2165669	usd
CY2022Q2	afcg	Incentive Compensation IncentiveCompensation	3400000	usd
	afcg	Incentive Compensation IncentiveCompensation	6400000	usd
CY2021Q2	afcg	Incentive Compensation IncentiveCompensation	1400000	usd
	afcg	Incentive Compensation IncentiveCompensation	2100000	usd
	afcg	Incentive Compensation IncentiveCompensation	6373864	usd
	afcg	Incentive Compensation IncentiveCompensation	2104777	usd
CY2022Q2	us-gaap	Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty	973886	usd
CY2021Q2	us-gaap	Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty	423939	usd
	us-gaap	Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty	1880603	usd
	us-gaap	Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty	789506	usd
CY2022Q2	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	1294594	usd
CY2021Q2	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	819531	usd
	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	2550461	usd
	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	1271206	usd
CY2022Q2	us-gaap	Related Party Transaction Other Revenues From Transactions With Related Party RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty	488050	usd
CY2021Q2	us-gaap	Related Party Transaction Other Revenues From Transactions With Related Party RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty	182707	usd
	us-gaap	Related Party Transaction Other Revenues From Transactions With Related Party RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty	875543	usd
	us-gaap	Related Party Transaction Other Revenues From Transactions With Related Party RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty	420450	usd
CY2022Q2	afcg	Related Party Transaction Base Management Fees Net RelatedPartyTransactionBaseManagementFeesNet	806544	usd
CY2021Q2	afcg	Related Party Transaction Base Management Fees Net RelatedPartyTransactionBaseManagementFeesNet	636824	usd
	afcg	Related Party Transaction Base Management Fees Net RelatedPartyTransactionBaseManagementFeesNet	1674918	usd
	afcg	Related Party Transaction Base Management Fees Net RelatedPartyTransactionBaseManagementFeesNet	850756	usd
CY2022Q2	afcg	Incentive Compensation IncentiveCompensation	3395024	usd
CY2022Q2	us-gaap	Related Party Costs RelatedPartyCosts	5175454	usd
CY2021Q2	us-gaap	Related Party Costs RelatedPartyCosts	2502810	usd
	us-gaap	Related Party Costs RelatedPartyCosts	9929385	usd
	us-gaap	Related Party Costs RelatedPartyCosts	3745039	usd
	afcg	Number Of Co Invested Loans Held NumberOfCoInvestedLoansHeld	5	loan

Files In Submission

Name	View Source	Status
0001822523-22-000005-index-headers.html	Edgar Link	pending
0001822523-22-000005-index.html	Edgar Link	pending
0001822523-22-000005.txt	Edgar Link	pending
0001822523-22-000005-xbrl.zip	Edgar Link	pending
afcg-20220630.htm	Edgar Link	pending
afcg-20220630.xsd	Edgar Link	pending
afcg-20220630xex311.htm	Edgar Link	pending
afcg-20220630xex312.htm	Edgar Link	pending
afcg-20220630xex321.htm	Edgar Link	pending
afcg-20220630xex322.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
afcg-20220630_lab.xml	Edgar Link	unprocessable
afcg-20220630_pre.xml	Edgar Link	unprocessable
afcg-20220630_def.xml	Edgar Link	unprocessable
afcg-20220630_htm.xml	Edgar Link	completed
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
afcg-20220630_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AFCG
Advanced Flower Capital Inc. Stock $afcg

2022 Q3 Form 10-Q Financial Statement

#000182252322000005 Filed on August 09, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AFCG Advanced Flower Capital Inc. Stock $afcg

2022 Q3 Form 10-Q Financial Statement

#000182252322000005 Filed on August 09, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AFCG
Advanced Flower Capital Inc. Stock $afcg